Literature DB >> 26829569

Stevens-Johnson syndrome: The role of an ophthalmologist.

Rajat Jain1, Namrata Sharma2, Sayan Basu3, Geetha Iyer4, Mayumi Ueta5, Chie Sotozono6, Chitra Kannabiran7, Varsha M Rathi8, Nidhi Gupta9, Shigeru Kinoshita6, José A P Gomes10, James Chodosh11, Virender S Sangwan12.   

Abstract

Stevens-Johnson syndrome (SJS) is an acute blistering disease of the skin and mucous membranes. Acute SJS leads to the acute inflammation of the ocular surface and chronic conjunctivitis. If not properly treated, it causes chronic cicatricial conjunctivitis and cicatricial lid margin abnormalities. Persistent inflammation and ulceration of the ocular surface with cicatricial complications of the lids leads to chronic ocular sequelae, ocular surface damage, and corneal scarring. The destruction of the glands that secrete the tear film leads to a severe form of dry eye that makes the management of chronic SJS difficult. The option that is routinely used for corneal visual rehabilitation, keratoplasty, is best avoided in such cases. We describe the management strategies that are most effective during the acute and chronic stages of SJS. Although treatments for acute SJS involve immunosuppressive and immunomodulatory therapies, amniotic membrane transplantation is also useful. The options for visual rehabilitation in patients with chronic SJS are undergoing radical change. We describe the existing literature regarding the management of SJS and highlight recent advances in the management of this disorder.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Stevens-Johnson syndrome; acute; dry eye; keratoprosthesis; stem cell transplantation: PROSE

Mesh:

Year:  2016        PMID: 26829569     DOI: 10.1016/j.survophthal.2016.01.004

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  13 in total

Review 1.  [Differential diagnoses of dry eye syndrome and blepharitis].

Authors:  M C Herwig-Carl; K U Loeffler
Journal:  Ophthalmologe       Date:  2018-02       Impact factor: 1.059

2.  Bilateral panophthalmitis following toxic epidermal necrolysis: A case report.

Authors:  Sharad Haribhau Shegaonkar
Journal:  Indian J Ophthalmol       Date:  2020-03       Impact factor: 1.848

3.  Cytokeratin profile and keratinocyte gene expression in keratinized lid margins of patients with chronic Stevens-Johnson syndrome.

Authors:  Madhuri Amulya Koduri; Jilu Jaffet; Swapna S Shanbhag; Sayan Basu; Vivek Singh; Swati Singh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-04-23       Impact factor: 3.535

4.  Prosthetic Replacement of the Ocular Surface Ecosystem Treatment for Ocular Surface Disease in Pediatric Patients With Stevens-Johnson Syndrome.

Authors:  Yvonne Wang; Rohini Rao; Deborah S Jacobs; Hajirah N Saeed
Journal:  Am J Ophthalmol       Date:  2019-01-19       Impact factor: 5.258

Review 5.  Analysis of the Pathogenic Factors and Management of Dry Eye in Ocular Surface Disorders.

Authors:  Marcella Nebbioso; Paola Del Regno; Magda Gharbiya; Marta Sacchetti; Rocco Plateroti; Alessandro Lambiase
Journal:  Int J Mol Sci       Date:  2017-08-13       Impact factor: 5.923

6.  A diagnosis of Stevens-Johnson Syndrome (SJS) in a patient presenting with superficial keratitis.

Authors:  Forson Chan; Matthew D Benson; David J A Plemel; Muhammad N Mahmood; Stanley M Chan
Journal:  Am J Ophthalmol Case Rep       Date:  2018-06-19

Review 7.  A New Perspective on Dry Eye Classification: Proposal by the Asia Dry Eye Society.

Authors:  Kazuo Tsubota; Norihiko Yokoi; Hitoshi Watanabe; Murat Dogru; Takashi Kojima; Masakazu Yamada; Shigeru Kinoshita; Hyo-Myung Kim; Hung-Won Tchah; Joon Young Hyon; Kyung Chul Yoon; Kyoung Yul Seo; Xuguang Sun; Wei Chen; Lingyi Liang; Mingwu Li; Louis Tong; Fung-Rong Hu; Vilavun Puangsricharern; Ruben Lim-Bon-Siong; Then Kong Yong; Zuguo Liu; Jun Shimazaki
Journal:  Eye Contact Lens       Date:  2020-01       Impact factor: 3.152

8.  Management of Stevens-Johnson Syndrome-Toxic Epidermal Necrolysis: Looking Beyond Guidelines!

Authors:  Rajesh Kumar; Anupam Das; Sudip Das
Journal:  Indian J Dermatol       Date:  2018 Mar-Apr       Impact factor: 1.494

9.  In vitro validation of the tear matrix metalloproteinase 9 in-situ immunoassay.

Authors:  Seung Pil Bang; Myeong Jin Son; Harim Kim; You Hyun Lee; Jong Hwa Jun
Journal:  Sci Rep       Date:  2020-09-15       Impact factor: 4.379

10.  Predictive biomarkers for the progression of ocular complications in chronic Stevens-Johnson syndrome and toxic Eeidermal necrolysis.

Authors:  Yamato Yoshikawa; Mayumi Ueta; Hiromi Nishigaki; Shigeru Kinoshita; Tsunehiko Ikeda; Chie Sotozono
Journal:  Sci Rep       Date:  2020-11-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.